Health service support

Health Service Support in a Nuclear, Biological, and Chemical Environment Tactics, Techniques,... 

There is evidence that a few Marine bases have achieved some level of a civilian-military joint venture in health service support, particularly in disaster situations. Such practices are also followed by other naval installations (notably, nuclear shipyards) in regard to radiation health and by a few Navy hospitals. However, even if put in place, a health surveillance system will only be effective if its health care providers are properly trained in its use and interpretation—and the committee has already noted the shortcomings in medical training in general. 

Directed Energy Weapons. Directed-energy weapons are likely to cause large numbers of casualties and equipment disruptions if countermeasures are not in place. Health service support units have adequate organization, doctrine, and resources to address low-level lasers. 

FM 8-10. Health Service Support in a Theater of Operations. 1 March 1991. 

FM 8-10-7. Health Service Support in a Nuclear, Biological, and Chemical Environment. April 1993 with change 1 dated Nov 96. This manual provides doctrine and tactics, techniques, and procedures for medical units and personnel operating in a nuclear, biological, and chemical (NBC) environment This manual is intended for all echelons of health service support (HSS). It discusses the operational aspects of the following HSS activities Medical treatment, medical evacuation, health service logistics, combat stress control, and preventive medicine, veterinary, dental, and medical laboratory services. 

HEALTH SERVICE SUPPORT ON THE BATTLEFIELD Echelon I The Unit Level Echelon II The Division Level Echelon III The Corps Level Echelon IV The Echelon Above Corps Echelon V The Continental United States... 

A brief review of pertinent Health Service Support (HSS) doctrine will provide a background for the discussion of chemical casualty care. The basic objectives of HSS are to... 

Each installation with a chemical surety mission is required to develop detailed plans and procedures to be implemented by the emergency actions community in response to a Chemical (Surety Material) Accident or Incident (CAI). Health services support during Chemical Accident or Incident Response and Assistance (CAIRA) operations involves personnel with a wide range of medical expertise who will be involved in providing emergency care. 

European Union (EU) (2010) Zimbabwe-Vital Health Services Support Programme, Phase I and II. Draft Evaluation Report, Harare, Zimbabwe. 

The authors thank D. H. Murray and E. J. Hedgley for samples of compounds 9 and 11, respectively. The support of grants GM-12328 and AI-07570 from the National Institutes of Health, U. S. Public Health Service, is acknowledged by D. C. Dejongh. The mass spectrometer was purchased by Wayne State University under Grant CP-1476 from the National Science Foundation. 

This work was supported by National Science Foundation grant DMB-841S499 from the Biophysics program, and Public Health Service grant GM-21479 from the Institute of General Medical Sciences. 

Supported In part by U.S. Public Health Service Grants HL-05168 and HL-15158. 

Supported by Grant AT(11-1)-3140 from the U.S. Energy Research Development Agency and by Public Health Service Contract HSM 99-72-24 from the National Institute of Occupational Safety Health. 

This research program was supported by Public Health Service Contract NOl-CP-55666 and National Cancer Institute Grant IPOl CA 29580. 

The research described is supported in part by U S Public Health Service grants CA-12376 and CA-29602 from the National Cancer Institute, and by a gift from Hoffmann-LaRoche, Inc ... 

This work was supported by Grant No. P01-CA25100 from the U.S. Public Health Service. We thank the National Cancer Institute for the loan of the thermal energy analyzer under Contract No. NOl-CP-33278. 

This work was supported by United States Public Health Service National Institutes of Health Grant GM24784. 

Work presented from the author s laboratory was supported by United States Public Health Service Grants (DK-33793, DK-42921 and AM-01423). The author was also the recipient of a New Investigator Award from the American Heart Association Connecticut Affiliate, Inc. The author is grateful to Peter S. Aronson for his mentorship and critical review of the manuscript. 

Work supported in part by Public Health Service grant DA 01642 and by funding from the World Health Organization, the U.S. Drug Enforcement Administration, the VCU Grant-in-Aid Program, and the A.D. Williams Fund. 

This review and research were supported in part by U.S. Public Health Service research grant DA 02632 and AA 05122. Mr. J.T. Sopko provided expert assistance in preparing the illustrations, the computerized bibliographic data base, as well as in conducting the experimental work. 

This work was supported by U.S. Public Health Service grants DA 00869 and DA 04222. The National Institute of Drug Abuse contributed the methamphetamine hydrochloride. MDMA, and MDA, NOVO Industrials is acknowledged for contributing GBR 12909. 

The authors acknowledge generous financial support (for R. D. H.) from the University of the Witwatersrand and the Foundation for Research Development. In addition, R. D. H. thanks A E. M. for hosting him as a Visiting Professor to Texas A M, when this review was written. Support was provided by Grant No. CA-42925, National Cancer Institute, U. S. Public Health Service. 

Our work has been supported mainly by the Army Research Office, Air Force Office of Scientific Research, Office of Naval Research, and the Public Health Service through the National Heart, Lung, and Blood Institute. 

Some of the research reported in this review was supported by grants from the United States Public Health Service AM 12599, the National Science Foundation NSF GB 26593X, and the Dow Chemical Company. 

ATSDR. 1996a. 1995 CERCLA priority list of hazardous substances that will be the subject of toxicological profiles and support document. Atlanta, GA US Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry. 

There is a long-standing habit in the health economics literature of supporting the need to regulate health care services in market failures such as information asymmetries, complexity and uncertainty, indivisibilities and externalities. These imperfections are also present in the market of a resource that is very important in the health service production process pharmaceutical products. However, the pharmaceutical market also presents certain specific characteristics that are of particular importance and have been used as arguments in favour of the need to adopt public policies of price intervention and regulation. 

---